UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mumps Outbreaks in Vaccinated Populations: Are Available Mumps Vaccines Effective Enough to Prevent Outbreaks?

Clinical infectious diseases, 2008-12, Vol.47 (11), p.1458-1467

2008

Volltextzugriff (PDF)

Economic Impact of Dengue Illness in the Americas

The American journal of tropical medicine and hygiene, 2011-02, Vol.84 (2), p.200-207

2011

Volltextzugriff (PDF)

Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical Trials

PLoS neglected tropical diseases, 2016-07, Vol.10 (7), p.e0004821

2016

Volltextzugriff (PDF)

The Epidemiology of Dengue in the Americas Over the Last Three Decades: A Worrisome Reality

The American journal of tropical medicine and hygiene, 2010-01, Vol.82 (1), p.128-135

2010

Volltextzugriff (PDF)

Implications of a 2005 Measles Outbreak in Indiana for Sustained Elimination of Measles in the United States

The New England journal of medicine, 2006-08, Vol.355 (5), p.447-455

2006

Volltextzugriff (PDF)

Long-Term Persistence of Mumps Antibody after Receipt of 2 Measles-Mumps-Rubella (MMR) Vaccinations and Antibody Response after a Third MMR Vaccination among a University Population

The Journal of infectious diseases, 2008-06, Vol.197 (12), p.1662-1668

2008

Volltextzugriff (PDF)

Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virus

Viruses, 2013-12, Vol.5 (12), p.3048-3070

2013

Volltextzugriff (PDF)

Mumps Vaccine Performance among University Students during a Mumps Outbreak

Clinical infectious diseases, 2008-04, Vol.46 (8), p.1172-1180

2008

Volltextzugriff (PDF)

Seroprevalence of Antibody to Mumps Virus in the US Population, 1999–2004

The Journal of infectious diseases, 2010-09, Vol.202 (5), p.667-674

2010

Volltextzugriff (PDF)

Review: The History of Dengue Outbreaks in the Americas

The American journal of tropical medicine and hygiene, 2012-10, Vol.87 (4), p.584-593

2012

Volltextzugriff (PDF)

Seroprevalence of Measles Antibody in the US Population, 1999–2004

The Journal of infectious diseases, 2007-11, Vol.196 (10), p.1459-1464

2007

Volltextzugriff (PDF)

The history of dengue outbreaks in the Americas

The American journal of tropical medicine and hygiene, 2012-10, Vol.87 (4), p.584-593

2012

Volltextzugriff (PDF)

The cost of containing one case of measles: the economic impact on the public health infrastructure--Iowa, 2004

Pediatrics (Evanston), 2005-07, Vol.116 (1), p.e1-e4

2005

Volltextzugriff (PDF)

Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention

Expert review of vaccines, 2016-11, Vol.15 (11), p.1373-1392

2016

Volltextzugriff (PDF)

Serologic Response to Inactivated Poliovirus Vaccine: A Randomized Clinical Trial Comparing 2 Vaccination Schedules in Puerto Rico

The Journal of infectious diseases, 2007-01, Vol.195 (1), p.12-20

2007

Volltextzugriff (PDF)

Detection of RNA of Mumps Virus during an Outbreak in a Population with a High Level of Measles, Mumps, and Rubella Vaccine Coverage

Journal of Clinical Microbiology, 2008-03, Vol.46 (3), p.1101-1103

2008

Volltextzugriff (PDF)

Guidance for Isolation Precautions for Mumps in the United States: A Review of the Scientific Basis for Policy Change

Clinical infectious diseases, 2010-06, Vol.50 (12), p.1619-1628

2010

Volltextzugriff (PDF)

Efficacy after 1 and 2 doses of CYD-TDV in dengue endemic areas by dengue serostatus

Vaccine, 2020-09, Vol.38 (41), p.6472-6477

2020

Volltextzugriff (PDF)

Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults ≥50 years of age

Vaccine, 2012-10, Vol.30 (47), p.6656-6664

2012

Volltextzugriff (PDF)

Assessment of the long-term efficacy of a dengue vaccine against symptomatic, virologically-confirmed dengue disease by baseline dengue serostatus

Vaccine, 2020-04, Vol.38 (19), p.3531-3536

2020

Volltextzugriff (PDF)

Accuracy and efficacy of pre-dengue vaccination screening for previous dengue infection with five commercially available immunoassays: a retrospective analysis of phase 3 efficacy trials

The Lancet infectious diseases, 2021-04, Vol.21 (4), p.529-536

2021

Volltextzugriff (PDF)

Safety and immunogenicity of three tetravalent dengue vaccine formulations in healthy adults in the USA

Vaccine, 2013-10, Vol.31 (44), p.5047-5054

2013

Volltextzugriff (PDF)

Immunogenicity and safety of a recombinant tetravalent dengue vaccine in children and adolescents ages 9-16 years in Brazil

The American journal of tropical medicine and hygiene, 2013-12, Vol.89 (6), p.1058-1065

2013

Volltextzugriff (PDF)

Analysis of Hospitalized and Severe Dengue Cases Over the 6 years of Follow-up of the Tetravalent Dengue Vaccine (CYD-TDV) Efficacy Trials in Asia and Latin America

Clinical infectious diseases, 2021-09, Vol.73 (6), p.1003-1012

2021

Volltextzugriff (PDF)

Immunobridging efficacy of a tetravalent dengue vaccine against dengue and against hospitalized dengue from children/adolescents to adults in highly endemic countries

Transactions of the Royal Society of Tropical Medicine and Hygiene, 2021-07, Vol.115 (7), p.750-763

2021

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(59)
Buchkapitel
(2)

Sprache

Englisch
(61)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Mumps Outbreaks in Vaccinated Populations: Are Available Mumps Vaccines Effective Enough to Prevent Outbreaks?

Economic Impact of Dengue Illness in the Americas

Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical Trials

The Epidemiology of Dengue in the Americas Over the Last Three Decades: A Worrisome Reality

Implications of a 2005 Measles Outbreak in Indiana for Sustained Elimination of Measles in the United States

Long-Term Persistence of Mumps Antibody after Receipt of 2 Measles-Mumps-Rubella (MMR) Vaccinations and Antibody Response after a Third MMR Vaccination among a University Population

Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virus

Mumps Vaccine Performance among University Students during a Mumps Outbreak

Seroprevalence of Antibody to Mumps Virus in the US Population, 1999–2004

Review: The History of Dengue Outbreaks in the Americas

Seroprevalence of Measles Antibody in the US Population, 1999–2004

The history of dengue outbreaks in the Americas

The cost of containing one case of measles: the economic impact on the public health infrastructure--Iowa, 2004

Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention

Serologic Response to Inactivated Poliovirus Vaccine: A Randomized Clinical Trial Comparing 2 Vaccination Schedules in Puerto Rico

Detection of RNA of Mumps Virus during an Outbreak in a Population with a High Level of Measles, Mumps, and Rubella Vaccine Coverage

Guidance for Isolation Precautions for Mumps in the United States: A Review of the Scientific Basis for Policy Change

Efficacy after 1 and 2 doses of CYD-TDV in dengue endemic areas by dengue serostatus

Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults ≥50 years of age

Assessment of the long-term efficacy of a dengue vaccine against symptomatic, virologically-confirmed dengue disease by baseline dengue serostatus

Accuracy and efficacy of pre-dengue vaccination screening for previous dengue infection with five commercially available immunoassays: a retrospective analysis of phase 3 efficacy trials

Safety and immunogenicity of three tetravalent dengue vaccine formulations in healthy adults in the USA

Immunogenicity and safety of a recombinant tetravalent dengue vaccine in children and adolescents ages 9-16 years in Brazil

Analysis of Hospitalized and Severe Dengue Cases Over the 6 years of Follow-up of the Tetravalent Dengue Vaccine (CYD-TDV) Efficacy Trials in Asia and Latin America

Immunobridging efficacy of a tetravalent dengue vaccine against dengue and against hospitalized dengue from children/adolescents to adults in highly endemic countries

Suchergebnisse filtern